Homocysteine concentrations in follicular fluid are associated with poor oocyte and embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction

Human Reproduction

Volumn 24, Issue 9, 2009, Pages 2293-2302

  Berker, Bülent ^a   Kaya, Cemil ^b   Aytac, Rusen ^a   Satiroglu, Hakan ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

Author keywords

Assisted reproduction; Homocysteine; Malonyldialdehyde; Polycystic ovary syndrome

Indexed keywords

CYANOCOBALAMIN; ESTRADIOL; FOLIC ACID; HOMOCYSTEINE; LEUPRORELIN; MALONALDEHYDE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; EMBRYO; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FOLIC ACID BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; VITAMIN BLOOD LEVEL;

ADULT; EMBRYO, MAMMALIAN; ESTRADIOL; FEMALE; FOLIC ACID; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; HOMOCYSTEINE; HUMANS; INFERTILITY, FEMALE; MALONDIALDEHYDE; OOCYTES; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; REPRODUCTIVE TECHNIQUES, ASSISTED; VITAMIN B 12;

EID: 68949213041     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep069     Document Type: Article

References (66)

1. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophsiology of human reproduction. Fertil Steril 2003;79:829- 843.
2. Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertility - a clinician's perspective. Reprod Biomed Online 2005;11:641-650.
3. Appasamy M, Jauniaux E, Serhal P, Al-Qahtani A, Groome NP, Muttukrishna S. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation. Fertil Steril 2008;89:912-921.
4. Ashkenazi J, Feldberg D, Dicker D, Veshaya A, Ayalan D, Goldman JA. IVF-embryo transfer in women with refractory polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 1989;30:157-161.
5. Attaran M, Pasqualotto E, Falcone T, Goldberg JM, Miller KF, Agarwal A, Sharma RK. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med 2000;45:314- 320.
6. Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082-1089.
7. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-501.
8. Barnes FL, Kausche A, Tiglias J, Wood C, Wilton L, Transon A. Production of embryos from in vitro matured primary human oocytes. Fertil Steril 1996;65:1151-1156.
9. Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 2002;55:882-887.
10. Betteridge DJ. What is the oxidative stress? Metabolism 2000;49:13-18.
11. Botero-Ruiz W, Laufer N, DeCherney A, Polan M, Haseltine F, Behrman H. The relationship between follicular fluid steroid concentration and successful fertilization of human oocytes in vitro. Fertil Steril 1984;41:820-826.
12. Boxmeer JC, Steegers-Theunissen RP, Lindemans J, Wildhagen MF, Martini E, Steegers EA, Macklon NS. Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation. Hum Reprod 2008a;23:2570-2576.
13. Boxmeer JC, Montserrate Brouns R, Lindemans J, Steegers EAP, Martini E, Macklon NS, Steegers-Theunissen RPM. Preconception folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertil Steril 2008b;89:1766-1770.
14. Cano F, Garcia-Velasco JA, Millet A, Remohi J, Simon C, Pellicier A. Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Asist Reprod Genet 1997;14:254-260.
15. Carson R, Trounson A, Findlay J. Successful fertilisation of human oocytes in vitro: concentration of estradiol-17 beta, progesterone and androstenedione in the antral fluid of donor follicles. J Clin Endocrinol Metab 1982;55:798-800.
16. Das S, Chattopadhyay RC, Ghosh S, Goswami SK, Chakravarty BN. Reactive oxygen species level in Follicular fluid-embryo quality marker in IVF? Hum Reprod 2006;21:2403-2407.
17. Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999;14:601-605.
18. Dor J, Ben-Shlomo I, Levran D, Rudak E, Yunish M, Mashizch S. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilisation. Fertil Steril 1992;58:986-990.
19. Ebisch IMW, Peters WH, Thomas CM, Wetzels AM, Peer PG, Steegers-Theunissen RP. Homocysteine, glutathione and related thiols affect fertility parameters in the (sub)fertile couple. Hum Reprod 2006;21:1725-1733.
20. Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Lin Tan S. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 1999;14:167-171.
21. Fonseca V, Guba SC, Fink LM. Hyperhomocysteinaemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev 1999;20:738-759.
22. Foong SC, Abbott DH, Lesnick TG, Session DR, Walker DL, Dumesic DA. Diminished intrafollicular estacadiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant humidon follicle-stimulating hormone. Fertil Steril 2005;83:1377-1383.
23. Franks S. Gonadotrophin regimens and oocyte quality in women with polycystic ovary syndrome. Reprod Biomed Online 2002;6:181-184.
24. Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries 1995.
25. Hardy K, Wright CS, Franks S, Winston RML. In vitro maturation of oocytes. Br Med Bull 2000;56:588-602.
26. Heijnen EMEW, Eijkemans MJC, Hughes EG, Laven JSE, Macklon NS, Fauser BCJM. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:13-21.
27. Ho JS, Gargano M, Cao J, Bronson RT, Heimler I, Hutz RJ. Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J Biol Chem 1998;273:7765-7769.
28. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024-1026.
29. Homburg R, Berkovitz D, Levy T, Feldberg D, Ashkazanozi B-R. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993;60:858-863.
30. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015- 20222.
31. Jabara S, Coutifaris C. In vitro fertilization in the PCOS patient: clinical considerations. Semin Reprod Med 2003;21:317- 324.
32. Jozwik M, Wolczynski S, Jozwik M, Szamatowicz M. Oxidative stress markers in preovulatory follicular fluid in humans. Mol Hum Reprod 1999;5:409-413.
33. Kaya C, Cengiz SD, Berker B, Demirtas S, Cesur M, Erdogan G. Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective, randomized study. Fertil Steril 2008. August 8 [Epub ahead of print].
34. Kodama H, Fukuda J, Karube H et al. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 1995;10;:1962-1967.
35. Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust NZ J Obstet Gynaecol 2001;41:65-68.
36. Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest 2002;53:157-162.
37. Ludwig M, Finas DF, Al-Hasani S, Diedrich K, Ortmann O. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 1999;14:354-358.
38. Martikainen H, Tiitinen A, Tomas C, Tapanainen J, Orava M, Tuomivaara L et al. One versus two embryo transfer after IVF and ICSI: a randomized study. Hum Reprod 2001;16:1900-1903.
39. McCarty MF. Increased homocysteine associated with smoking, chronic inflammation, and ageing may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypoth 2000;55:289-293.
40. Mulders A. IVF outcome in anovulatory infertility (WHO-group 2)-including polycystic ovary syndrome-following previous unsuccessful ovulation induction. Reprod Biomed Online 2003;7:50-58.
41. Oyawoye O, Abdel Gadir A, Garner A, Constantinovici N, Perrett C, Hardiman P. Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod 2003;18:2270-2274.
42. Pellicer A, Miro F, Sampaio M, Gomez E, Bonilla-Musoles F. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril 1991;55:970-975.
43. Pellicer A, Valbuena D, Cano F, Remohi J, Simón C. Lower implantation rates in high responders (evidence for an altered endocrine milieu during the preimplantation period). Fertil Steril 1996;65:1190- 1195.
44. Plachot M, Belaisch-Allart J, Chouraqui A, Tesquier A, Serkine AM, Agabeyrached F. Oocyte and embryo quality in polycystic ovary syndrome. Gynecol Obstet Fertil 2003;31:350-354.
45. Plachta H, Bartnikowska E, Obara A. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries. Clin Chim Acta 1992;211:101-112.
46. Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente C, Lunerfled B, Mashizch S. In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab 1989;68:693-697.
47. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336:1141-1144.
48. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
49. Sahu B, Ozturk O, Rainerri M, Serhal P. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 2008;277:239-244.
50. Salat-Baroux J, Alvarez S, Antoine JM, Cornet D, Tibi C, Plachat M, Mandelbaum J. Results of IVF in the treatment of polycystic ovary disease. Hum Reprod 1988;3:331-335.
51. Schacter M, Raziel A, Friedler S, Starssburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003;8:721-727.
52. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-131.
53. Sengoku K, Tamate K, Takuma N, Yoshida T, Golshik, Ishikawa M. The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod 1997;12:474-477.
54. Spitzer D, Murach KF, Lottspeich F, Staudach A, Illmensee K. Different protein patterns derived from follicular fluid of mature and immature human follicles. Hum Reprod 1996;11:798-807.
55. Steegers-Theunissen RP, Boers GH, Blom HJ, Trijbels FJ, Eskes TK. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentace. Lancet 1992;339:1122-1123.
56. Steegers-Theunissen RP, Steegers EA, Thomas CM, Hollanders HM, Peereboom-Stegeman JH, Trijbels FJ, Eskes TK. Study on the presence of homocysteine in ovarian follicular fluid. Fertil Steril 1993;60:1006-1010.
57. Teissier M, Chable H, Paulhac S, Aubard Y. Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Hum Reprod 2000;15:2471-2477.
58. Tesarik J, Mendoza C. Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995;80:1438-1443.
59. Van Royen E, Mangelschots K, De Neubourg D, Valkenburtg M, Van de Meerssche M, Ryckaert G, Eestermans W, Gemis J. Characterization of a top quality embryo, a step towards single-embryo transfer. Hum Reprod 1999;14:2345-2349.
60. Veeck LL. An Atlas of Human Gametes and Conceptuses: An Illustrated Reference for Assisted Reproductive Technology. New York: Parthenon Publishing, 1999.
61. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
62. Weghofer A, Munne S, Chen S, Barad D, Gleicher N. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007;88:900-905.
63. World Health Organization. Laboratory Manual for the Examination of Human Semen and Sperm-Servical Mucus Interaction, 4th edn. New York: Cambridge University Pres, 1999.
64. Wramsby H, Kullander S, Liedholm P, Rannevik G, Sundstrom P, Thorell J. The success rate of in vitro fertilization of human oocytes in relation to the concentrations of different hormones in follicular fluid and peripheral plasma. Fertil Steril 1981;36:448-454.
65. Yarali H, Yildirir A, Aybar F, Kabakci G, Bukumez O, Akgul E, Oto A. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 2001;76:511-516.
66. Yildirim B, Demir S, Temur I, Erdemir R, Kaleli B. Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome during assisted reproduction cycles. J Reprod Med 2007;52:722-726.